Increased incidence of psychiatric disorders in immune-mediated inflammatory disease

Journal of Psychosomatic Research

Volumn 101, Issue , 2017, Pages 17-23

  Marrie, Ruth Ann ^a   Walld, Randy ^a   Bolton, James M ^a   Sareen, Jitender ^a   Walker, John R ^a   Patten, Scott B ^b   Singer, Alexander ^a   Lix, Lisa M ^a   Hitchon, Carol A ^a   El Gabalawy, Renée ^a   Katz, Alan ^a   Fisk, John D ^a,c   Bernstein, Charles N ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Anxiety disorder; Bipolar disorder; Depression; Epidemiology; Inflammatory bowel disease; Multiple sclerosis; Rheumatoid arthritis

Indexed keywords

ADULT; AGED; ANXIETY DISORDER; ARTICLE; BIPOLAR DISORDER; CANADA; COHORT ANALYSIS; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; DEPRESSION; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; IMMUNE MEDIATED INFLAMMATORY DISEASE; INCIDENCE; INFLAMMATORY BOWEL DISEASE; INFLAMMATORY DISEASE; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MIDDLE AGED; MULTIPLE SCLEROSIS; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SCHIZOPHRENIA; SEX RATIO; SOCIAL STATUS; ADOLESCENT; COMPLICATION; IMMUNOPATHOLOGY; INFLAMMATION; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; COHORT STUDIES; COMORBIDITY; FEMALE; HUMANS; IMMUNE SYSTEM DISEASES; INCIDENCE; INFLAMMATION; MALE; MENTAL DISORDERS; MIDDLE AGED; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 85026777976     PISSN: 00223999     EISSN: 18791360     Source Type: Journal    
DOI: 10.1016/j.jpsychores.2017.07.015     Document Type: Article

References (61)

1. Rahman, P., Inman, R.D., El-Gabalawy, H., Krause, D.O., Pathophysiology and pathogenesis of immune-mediated inflammatory diseases: commonalities and differences. J. Rheumatol. 85 (2010), 11–26.
2. Pugliatti, M., Sotgiu, S., Rosati, G., The worldwide prevalence of multiple sclerosis. Clin. Neurol. Neurosurg. 104 (2002), 182–191.
3. Logan, I., Bowlus, C.L., The geoepidemiology of autoimmune intestinal diseases. Autoimmun. Rev. 9:5 (2010), A372–A378.
4. Alamanos, Y., Voulgari, P.V., Drosos, A.A., Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology Criteria: a systematic review. Semin. Arthritis Rheum. 36:3 (2006), 182–188.
5. Canadian Institute for Health Information, The Burden of Neurological Diseases, Disorders and Injuries in Canada, Ottawa. 2007.
6. Canada, Health, Arthritis in Canada: An Ongoing Challenge. 2003, Health Canada, Ottawa.
7. Bernstein, C.N., Longobardi, T., Finlayson, G., Blanchard, J.F., Direct medical cost of managing IBD patients: a Canadian population-based study. Inflamm. Bowel Dis. 18:8 (2012), 1498–1508.
8. Insel, T.R., Charney, D.S., Research on major depression: strategies and priorities. JAMA 289:23 (2003), 3167–3168.
9. Rapaport, M.H., Clary, C., Fayyad, R., Endicott, J., Quality-of-life impairment in depressive and anxiety disorders. Am. J. Psychiatry 162:6 (2005), 1171–1178.
10. Stein, M.B., Roy-Byrne, P.P., Craske, M.G., Bystritsky, A., Sullivan, G., Pyne, J.M., Katon, W., Sherbourne, C.D., Functional impact and health utility of anxiety disorders in primary care outpatients. Med. Care 43:12 (2005), 1164–1170.
11. Walker, E., McGee, R.E., Druss, B.G., Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysis. JAMA Psychiatry 72:4 (2015), 334–341.
12. Graff, L.A., Walker, J.R., Bernstein, C.N., Depression and anxiety in inflammatory bowel disease: a review of comorbidity and management. Inflamm. Bowel Dis. 15:7 (2009), 1105–1118.
13. Marrie, R.A., Reider, N., Cohen, J., Stuve, O., Trojano, M., Sorensen, P.S., Cutter, G., The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic review. Mult. Scler. J. 21:3 (2015), 305–317.
14. Mikocka-Walus, A., Knowles, S.R., Keefer, L., Graff, L., Controversies revisited: a systematic review of the comorbidity of depression and anxiety with inflammatory bowel diseases. Inflamm. Bowel Dis. 22:3 (2016), 752–762.
15. Marrie, R.A., Fisk, J.D., Tremlett, H., Wolfson, C., Warren, S., Tennakoon, A., Leung, S., Patten, S.B., Differences in the burden of psychiatric comorbidity in MS vs the general population. Neurology 85:22 (2015), 1972–1979.
16. Bernstein, C.N., Blanchard, J.F., Rawsthorne, P., Wajda, A., Epidemiology of Crohn's disease and ulcerative colitis in a central Canadian Province: a population-based study. Am. J. Epidemiol. 149:10 (1999), 916–924.
17. Marrie, R.A., Yu, N., Blanchard, J.F., Leung, S., Elliott, L., The rising prevalence and changing age distribution of multiple sclerosis in Manitoba. Neurology 74:6 (2010), 465–471.
18. Hitchon, C.A., Khan, S., Elias, B., El-Gabalawy, H.S., Katz, A., Peschken, C.A., First nations persons have an increased risk of developing rheumatoid arthritis with an early onset age but are seen less frequently by rheumatologists: A population based study. ACR/ARHP Annual Meeting, 2014, American College of Rheumatology, Boston, MA.
19. Marrie, R.A., Bernstein, C.N., Peschken, C.A., Hitchon, C.A., Chen, H., Fransoo, R., Garland, A., Intensive care unit admission in multiple sclerosis: increased incidence and increased mortality. Neurology 82:23 (2014), 2112–2119.
20. Marrie, R.A., Fisk, J.D., Yu, B.N., Leung, S., Elliott, L., Caetano, P., Warren, S., Evans, C., Wolfson, C., Svenson, L.W., Tremlett, H., Blanchard, J.F., Patten, S.B., Mental comorbidity and multiple sclerosis: validating administrative data to support population-based surveillance. BMC Neurol., 13(1), 2013, 16.
21. Marrie, R.A., Walker, J.R., Graff, L.A., Lix, L.M., Bolton, J.M., Nugent, Z., Targownik, L.E., Bernstein, C.N., Performance of administrative case definitions for depression and anxiety in inflammatory bowel disease. J. Psychosom. Res. 89 (2016), 107–113.
22. Chateau, D., Metge, C., Prior, H., Soodeen, R.A., Learning from the census: the Socio-economic Factor Index (SEFI) and health outcomes in Manitoba. Can. J. Public Health 103:8 Suppl 2 (2012), S23–7.
23. Rothman, K.J., Greenland, S., Modern Epidemiology. 1998, Lippincott Williams & Wilkins, Philadelphia, PA, 738.
24. Panara, A.J., Yarur, A.J., Rieders, B., Proksell, S., Deshpande, A.R., Abreu, M.T., Sussman, D.A., The incidence and risk factors for developing depression after being diagnosed with inflammatory bowel disease: a cohort study. Aliment. Pharmacol. Ther. 39:8 (2014), 802–810.
25. Ananthakrishnan, A.N., Gainer, V.S., Cai, T., Perez, R.G., Cheng, S.C., Savova, G., Chen, P., Szolovits, P., Xia, Z., De Jager, P.L., Shaw, S., Churchill, S., Karlson, E.W., Kohane, I., Perlis, R.H., Plenge, R.M., Murphy, S.N., Liao, K.P., Similar risk of depression and anxiety following surgery or hospitalization for Crohn's disease and ulcerative colitis. Am. J. Gastroenterol. 108:4 (2013), 594–601.
26. Severance, E.G., Gressitt, K.L., Yang, S., Stallings, C.R., Origoni, A.E., Vaughan, C., Khushalani, S., Alaedini, A., Dickerson, F.B., Yolken, R.H., Seroreactive marker for inflammatory bowel disease and associations with antibodies to dietary proteins in bipolar disorder. Bipolar Disord. 16:3 (2014), 230–240.
27. Cucino, C., Sonnenberg, A., The comorbid occurrence of other diagnoses in patients with ulcerative colitis and Crohn's disease. Am. J. Gastroenterol. 96:7 (2001), 2107–2112.
28. West, J., Logan, R.F., Hubbard, R.B., Card, T.R., Risk of schizophrenia in people with coeliac disease, ulcerative colitis and Crohn's disease: a general population-based study. Aliment. Pharmacol. Ther. 23:1 (2006), 71–74.
29. Patten, S.B., Berzins, S., Metz, L.M., Challenges in screening for depression in multiple sclerosis. Mult. Scler. J. 16:11 (2010), 1406–1411.
30. Thielscher, C., Thielscher, S., Kostev, K., The risk of developing depression when suffering from neurological diseases. German Med. Sci., 11, 2013 (Doc02).
31. Marrie, R.A., Patten, S.B., Greenfield, J., Svenson, L.W., Jette, N., Tremlett, H., Wolfson, C., Warren, S., Profetto-McGrath, J., Fisk, J.D., Blanchard, J., Caetano, P., Elliott, L., Yu, B.N., Bhan, V., Svenson, L., Physical comorbidities increase the risk of psychiatric comorbidity in multiple sclerosis. Brain Behav., 6(9), 2016, e00493.
32. Lu, M.C., Guo, H.R., Lin, M.C., Livneh, H., Lai, N.S., Tsai, T.Y., Bidirectional associations between rheumatoid arthritis and depression: a nationwide longitudinal study. Sci Rep, 6, 2016, 20647.
33. Isik, A., Koca, S.S., Ozturk, A., Mermi, O., Anxiety and depression in patients with rheumatoid arthritis. Clin. Rheumatol. 26:6 (2007), 872–878.
34. Farhi, A., Cohen, A.D., Shovman, O., Comaneshter, D., Amital, H., Amital, D., Bipolar disorder associated with rheumatoid arthritis: a case-control study. J. Affect. Disord. 189 (2016), 287–289.
35. Hsu, C.C., Chen, S.C., Liu, C.J., Lu, T., Shen, C.C., Hu, Y.W., Yeh, C.M., Chen, P.M., Chen, T.J., Hu, L.Y., Rheumatoid arthritis and the risk of bipolar disorder: a nationwide population-based study. PLoS One, 9(9), 2014, e107512.
36. Sellgren, C., Frisell, T., Lichtenstein, P., Landèn, M., Askling, J., The association between schizophrenia and rheumatoid arthritis: a nationwide population-based Swedish study on intraindividual and familial risks. Schizophr. Bull. 40:6 (2014), 1552–1559.
37. Eaton, W.W., Hayward, C., Ram, R., Schizophrenia and rheumatoid arthritis: a review. Schizophr. Res. 6:3 (1992), 181–192.
38. Wiens, K., Williams, J.V.A., Lavorato, D.H., Bulloch, A.G.M., Patten, S.B., The prevalence of major depressive episodes is higher in urban regions of Canada. Can. J. Psychiatr. 62:1 (2017), 57–61.
39. Chartier, M., Brownell, M., MacWilliam, L., Valdivia, J., Nie, Y., Ekuma, O., Burchill, C., Hu, M., Rajotte, L., Kulbaba, C., The Mental Health of Manitoba's Children. 2016, Manitoba Centre for Health Policy, Winnipeg.
40. Breslow, R.E., Klinger, B.I., Erickson, B.J., County drift: a type of geographic mobility of chronic psychiatric patients. Gen. Hosp. Psychiatry 20:1 (1998), 44–47.
41. Watterson, R.A., Williams, J.V.A., Lavorato, D.H., Patten, S.B., Descriptive epidemiology of generalized anxiety disorder in Canada. Can. J. Psychiatr. 62:1 (2017), 24–29.
42. Marrie, R.A., Cutter, G., Tyry, T., Campagnolo, D., Vollmer, T., Effect of physical comorbidities on risk of depression in multiple sclerosis. IJMSC 11:4 (2009), 161–166.
43. Lok, E.Y., Mok, C.C., Cheng, C.W., Cheung, E.F., Prevalence and determinants of psychiatric disorders in patients with rheumatoid arthritis. Psychosomatics, 51(4), 2010, 338 338.e8.
44. Hudson, C.G., Socioeconomic status and mental illness: tests of the social causation and selection hypotheses. Am. J. Orthop., 75(1), 2005, 3.
45. Cohen, S., Janicki-Deverts, D., Doyle, W.J., Miller, G.E., Frank, E., Rabin, B.S., Turner, R.B., Chronic stress, glucocorticoid receptor resistance, inflammation, and disease risk. Proc. Natl. Acad. Sci. U. S. A. 109:16 (2012), 5995–5999.
46. Schmeer, K.K., Yoon, A., Socioeconomic status inequalities in low-grade inflammation during childhood. Arch. Dis. Child. 101:11 (2016), 1043–1047.
47. Calcia, M.A., Bonsall, D.R., Bloomfield, P.S., Selvaraj, S., Barichello, T., Howes, O.D., Stress and neuroinflammation: a systematic review of the effects of stress on microglia and the implications for mental illness. Psychopharmacology 233:9 (2016), 1637–1650.
48. Pervanidou, P., Chrousos, G.P., Metabolic consequences of stress during childhood and adolescence. Metabolism 61:5 (2012), 611–619.
49. Steel, Z., Marnane, C., Iranpour, C., Chey, T., Jackson, J.W., Patel, V., Silove, D., The global prevalence of common mental disorders: a systematic review and meta-analysis 1980–2013. Int. J. Epidemiol. 43:2 (2014), 476–493.
50. Carta, M.G., Moro, M.F., Lorefice, L., Trincas, G., Cocco, E., Del Giudice, E., Fenu, G., Colom, F., Marrosu, M.G., The risk of bipolar disorders in multiple sclerosis. J. Affect. Disord. 155 (2014), 255–260.
51. Reynolds, K., Pietrzak, R.H., El-Gabalawy, R., Mackenzie, C.S., Sareen, J., Prevalence of psychiatric disorders in U.S. older adults: findings from a nationally representative survey. World Psychiatry 14:1 (2015), 74–81.
52. Charles, S.T., Strength and vulnerability integration: a model of emotional well-being across adulthood. Psychol. Bull. 136:6 (2010), 1068–1091.
53. Cross-Disorder Group of the Psychiatric Genomics Consortium, Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 381:9875 (2013), 1371–1379.
54. Pettersson, E., Larsson, H., Lichtenstein, P., Common psychiatric disorders share the same genetic origin: a multivariate sibling study of the Swedish population. Mol. Psychiatry, 2015, 10.10.38/p.2015.116 Online ahead of print.
55. Wang, Q., Yang, C., Gelernter, J., Zhao, H., Pervasive pleiotropy between psychiatric disorders and immune disorders revealed by integrative analysis of multiple GWAS. Hum. Genet. 134:11 (2015), 1195–1209.
56. Lotrich, F.E., El-Gabalawy, H., Guenther, L.C., Ware, C.F., The role of inflammation in the pathophysiology of depression: different treatments and their effects. J. Rheumatol. 88 (2011), 48–54.
57. Furtado, M., Katzman, M.A., Neuroinflammatory pathways in anxiety, posttraumatic stress, and obsessive compulsive disorders. Psychiatry Res. 229:1–2 (2015), 37–48.
58. Rosenblat, J.D., McIntyre, R.S., Are medical comorbid conditions of bipolar disorder due to immune dysfunction?. Acta Psychiatr. Scand. 132:3 (2015), 180–191.
59. Winkel, R.V., Nierop, M.V., Myin-Germeys, I., Os, J.V., Childhood trauma as a cause of psychosis: linking genes, psychology, and biology. Can. J. Psychiatr. 58:1 (2013), 44–51.
60. O'Donnell, S., Vanderloo, S., McRae, L., Onysko, J., Patten, S.B., Pelletier, L., Comparison of the estimated prevalence of mood and/or anxiety disorders in Canada between self-report and administrative data. Epidemiol. Psychiatr. Sci. 25:4 (2016), 360–369.
61. Mojtabai, R., Olfson, M., Sampson, N.A., Jin, R., Druss, B., Wang, P.S., Wells, K.B., Pincus, H.A., Kessler, R.C., Barriers to mental health treatment: results from the National Comorbidity Survey Replication. Psychol. Med. 41:8 (2011), 1751–1761.